Diphenhydramine salicylate
- Level
- Commodity
- Parent
- 51312300
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51312313This classification denotes a histamine-1 receptor antagonist and antiemetic agent with the molecular formula C17H21NO.C7H6O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 707L3YC54L, chemically known as 2-(diphenylmethoxy)-n,n-dimethylethylamine hydrochloride but more generally known as diphenhydramine salicylate, which bears US NIH Compound Identifier 3100. European Medicines Agency schedules Diphenhydramine salicylate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01774MIG. Most nations, for tariff and trade purposes, schedule diphenhydramine salicylate under HS 29221980 and SITC 51461. As of Q4 2014, DIPHENHYDRAMINE SALICYLATE remains US FDA's Preferred Term for this commodity. SMILES: CN(C)CCOC(C1CCCCC1)C2CCCCC2.C1CCC(C(C1)C(=O)O)O.
Same parent
Under 51312300 · 15Activities that produce or sell this
KBLI · 9Inherited from family 51310000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.